Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome. [electronic resource]
Producer: 20030605Description: 932-7 p. digitalISSN:- 0015-0282
- Adrenal Glands -- drug effects
- Adult
- Blood Glucose -- metabolism
- Chromans -- pharmacology
- Dehydroepiandrosterone Sulfate -- blood
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Glucose Tolerance Test
- Humans
- Hyperandrogenism -- blood
- Hyperinsulinism -- blood
- Hypoglycemic Agents -- pharmacology
- Insulin -- blood
- Insulin Resistance -- physiology
- Polycystic Ovary Syndrome -- blood
- Prospective Studies
- Thiazoles -- pharmacology
- Thiazolidinediones
- Troglitazone
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.